Clinton, Trump sprint to finish in final campaign appeals

November 8, 2016

Philadelphia, Nov 8: Closing out a wildly unpredictable White House race, Hillary Clinton and Donald Trump blitzed through battleground states Monday in a final bid to energize supporters. Clinton, backed by an emotional appeal from Barack Obama, urged voters to embrace a "hopeful, inclusive, bighearted America," while Trump vowed to "beat the corrupt system."

ClintonThe candidates rallied voters late into the night, a frenzied end to a bitter election year that has laid bare the nation's deep economic and cultural divides. Clinton and Trump were both nostalgic at times, looking back fondly at a campaign that has put each on the brink of the presidency.

Clinton campaigned with confidence, buoyed by FBI Director James Comey's announcement Sunday that he would not recommend criminal charges against her following a new email review. The FBI inquiry had sapped a surging Clinton momentum at a crucial moment in the race, though she still heads into Election Day with multiple paths to the 270 Electoral College votes needed to become the nation's first female president.

Clinton closed her campaign alongside the last two Democrats to occupy the Oval Office, Obama and her husband, former President Bill Clinton, as well as first lady Michelle Obama. In a nod to the deep divisions that await the next president, Clinton said she'd come to "regret deeply how angry the tone of the campaign became." She cast the choice facing voters Tuesday as a "test of our time."

"We know enough about my opponent, we know who he is," Clinton said, addressing tens of thousands of people sprawled across Philadelphia's Independence Mall. "The real question for us is what kind of country we want to be."

Obama's address amounted to a valedictory for a president whose popularity has grown in his final year in office.

"America, I'm betting on you one more time," Obama said. "I am betting that tomorrow you will reject fear and choose hope."

Trump, who sped through five rallies Monday, recalled the rivals he'd vanquished and how far he's come since launching his improbable candidacy. As he surveyed the crowd in Scranton, Pennsylvania, he declared, "It's been a long journey."

Still, Trump was aggressive to the end, slamming Clinton as the "face of failure." Having made the new FBI review a centerpiece of his closing case to voters, he argued that the Democrat was being protected by a "totally rigged system."

"You have one magnificent chance to beat the corrupt system and deliver justice," Trump said. "Do not let this opportunity slip away."

The comments were a reminder that Comey's news, delivered in a letter to lawmakers on Sunday, was a doubled-edged sword for Clinton. While it vindicated her claims that the emails would not yield new evidence, it ensured that a controversy that has dogged her campaign from the start would follow her through Election Day.

Across the country, nearly 24 million early ballots were cast under the shadow of Comey's initial announcement of a new email review. That number represents about half of the nearly 45 million people who had cast votes by Monday, according to Associated Press data.

The inquiry involved material found on a computer belonging to Anthony Weiner, the disgraced former congressman and estranged husband of Huma Abedin, a longtime Clinton aide. Comey said Sunday the FBI reviewed communications "to or from Hillary Clinton while she was secretary of state."

Clinton tried to fly above the controversy Monday, making no mention of the FBI during her rallies. She was closing out her campaigning with a midnight rally in Raleigh, North Carolina.

Clinton is banking in part on high turnout — particularly among Obama's young, diverse coalition of voters — to carry her over the finish line Tuesday. Roughly half the states with advance voting have reported record turnout, including Florida and Nevada, which have booming Hispanic populations, a possible good sign for Clinton.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 13,2020

New Delhi, Jul 13: Google CEO Sundar Pichai on Monday announced an investment of Rs 75,000 crore or approximately US$10 billion into India over the next five to seven years through 'Google for India Digistation Fund'.

This move is significant as it comes in the middle of the COVID-19 pandemic and as multinational companies across the world look at alternative investment destinations.

"Excited to announce Google for India Digitisation Fund. Through it, we will invest Rs 75,000 crore or approx US$10 Billon into India over the next 5-7 yrs. We'll do this through a mix of equity investments, partnerships and operational infrastructure in ecosystem investments," said Pichai.

Pichai along with Union Minister Ravi Shankar Prasad virtually attended the sixth annual edition of Google for India.

"This is a reflection of our confidence in the future of India and its digital economy," said Pichai.
He added that the investments will focus on four areas important to India's digitisation.

Listing out the areas, Pichai elaborated, "First enabling affordable access and information to every Indian in their own language. Second, building new products and services that are deeply relevant to India's unique needs. Third, empowering businesses as they continue or embark on the digital transformation. Fourth, leveraging technology in AI for social good in areas like health, education and agriculture."

"When I was young, every piece of technology brought new opportunities to learn and grow but I always had to wait for it to arrive from some places. Today people in India no more have to wait for technology to come to you. A whole new generation of technologies is happening in India first," said Pichai.

Earlier today Prime Minister Narendra Modi interacted with Pichai and discussed a range of subjects like a new work culture in coronavirus times, data security and cyber safety.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
February 25,2020

Kuala Lumpur, Feb 25: The government party led by Interim Malaysian Prime Minister Mahathir Mohamad has rejected his resignation, urging him to continue leading it and the country, now shrouded in political uncertainty.

During an extraordinary meeting held on Monday night, the Malaysian United Indigenous Party (Bersatu) unanimously rejected the 94-year-old Prime Minister's decision, reports Efe news.

Mahathir, the world's oldest head of government, presented his resignation on Monday, later accepted by King Abdullah Pahang, on condition that he continue as Interim Prime Minister until a new government is formed.

That decision caused a domino effect that broke the Patakan Harapan (Alliance of Hope) alliance, formed in 2018 by four political parties that prevailed in that year's general elections.

Bersatu and 11 Popular Justice Party deputies announced their departure from the coalition, although they reaffirmed their confidence in Mahathir as Malaysia's political leader.

"We remain intact and prepared to build a party to face the difficulties," Marzuki Yahya, Bersatu Secretary-General, said after the meeting.

Confusion reigns in the country, with some local media claiming Bersatu and the 11 deputies Justice Party deputies intended to form a new government with opposition parties, including the historic Barisan Nasional coalition, under Mahathir's leadership.

Lim Guan Eng, Finance Minister and coalition member, said in a statement that the chief executive himself had informed him he had no intention of forming a coalition with Barisan, which suffered a historic defeat in the last elections.

A future government will need at least 112 of 222 parliament votes.

Mahathir returned to politics in 2018 heading the Patakan Harapan coalition to defeat his predecessor Najib Razak, marred by the corruption suspicions offenses.

To that end, Mahathir joined Anwar Ibrahim, a former political ally who fell out of favour in 1999 and was imprisoned five years on charges of corruption and sodomy, whom he promised to be his successor in power.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.